Minna Kellomäki

Dr. Minna Kellomäki

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Annals of Medicine
Verified
Journal Article
Closed access
SPSanna M. Peltola
Sanna M. Peltola
Ferry MelchelsFerry Melchels
Ferry Melchels
DGDirk W. Grijpma
Dirk W. Grijpma
MKMinna Kellomäki
Minna Kellomäki
Rapid prototyping (RP) is a common name for several techniques, which read in data from computer-aided design (CAD) drawings and manufacture automatically three-dimensional objects layer-by-layer according to the virtual design. The utilization of RP in tissue engineering enables the production of three-dimensional scaffolds with complex geometries and very fine structures. Adding micro- and nanometer details into the scaffolds improves the mechanical properties of the scaffold and ensures better cell adhesion to the scaffold surface. Thus, tissue engineering constructs can be customized according to the data acquired from the medical scans to match the each patient's individual needs. In addition RP enables the control of the scaffold porosity making it possible to fabricate applications with desired structural integrity. Unfortunately, every RP process has its own unique disadvantages in building tissue engineering scaffolds. Hence, the future research should be focused on the development of RP machines designed specifically for fabrication of tissue engineering scaffolds, although RP methods already can serve as a link between tissue and engineering.

1 April 2002 in Biomaterials
Verified
Journal Article
Closed access
NBN.C. Bleach
N.C. Bleach
SNS.N. Nazhat
S.N. Nazhat
KTK.E. Tanner
K.E. Tanner
MKMinna Kellomäki
Minna Kellomäki
PTP. Törmälä
P. Törmälä

1 December 2000 in Biomaterials
Verified
Journal Article
Closed access
MKMinna Kellomäki
Minna Kellomäki
HNHenna Niiranen
Henna Niiranen
KPKatja Puumanen
Katja Puumanen
NANureddin Ashammakhi
Nureddin Ashammakhi
TWTimo Waris
Timo Waris
PTPertti Törmälä
Pertti Törmälä

1 December 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
AHAleksi Hänninen
Aleksi Hänninen
ESEssi Sarlin
Essi Sarlin
ILInari Lyyra
Inari Lyyra
TSTimo Salpavaara
Timo Salpavaara
MKMinna Kellomäki
Minna Kellomäki
STSampo Tuukkanen
Sampo Tuukkanen

1 May 2014 in Acta Biomaterialia
Verified
Journal Article
Open access
AGAndrew Gleadall
Andrew Gleadall
JPJingzhe Pan
Jingzhe Pan
MKMarc-Anton Kruft
Marc-Anton Kruft
MKMinna Kellomäki
Minna Kellomäki
A mathematical model was developed to relate the degradation trend of bioresorbable polymers to different underlying hydrolysis mechanisms, including noncatalytic random scission, autocatalytic random scission, noncatalytic end scission or autocatalytic end scission. The effect of each mechanism on molecular weight degradation and potential mass loss was analysed. A simple scheme was developed to identify the most likely hydrolysis mechanism based on experimental data. The scheme was first demonstrated using case studies, then used to evaluate data collected from 31 publications in the literature to identify the dominant hydrolysis mechanisms for typical biodegradable polymers. The analysis showed that most of the experimental data indicates autocatalytic hydrolysis, as expected. However, the study shows that the existing understanding on whether random or end scission controls degradation is inappropriate. It was revealed that pure end scission cannot explain the observed trend in molecular weight reduction because end scission would be too slow to reduce the average molecular weight. On the other hand, pure random scission cannot explain the observed trend in mass loss because too few oligomers would be available to diffuse out of a device. It is concluded that the chain ends are more susceptible to cleavage, which produces most of the oligomers leading to mass loss. However, it is random scission that dominates the reduction in molecular weight.

9 June 2008 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Open access
PDF file
MGManuela E Gomes
Manuela E Gomes
HAHelena Azevedo
Helena Azevedo
AMA. R. Moreira
A. R. Moreira
VEV. Ellä
V. Ellä
MKMinna Kellomäki
Minna Kellomäki
RRRui M. Reis
Rui M. Reis
In scaffold‐based tissue engineering strategies, the successful regeneration of tissues from matrix‐producing connective tissue cells or anchorage‐dependent cells (e.g. osteoblasts) relies on the use of a suitable scaffold. This study describes the development and characterization of SPCL (starch with ε‐polycaprolactone, 30:70%) and SPLA [starch with poly(lactic acid), 30:70%] fibre‐meshes, aimed at application in bone tissue‐engineering strategies. Scaffolds based on SPCL and SPLA were prepared from fibres obtained by melt‐spinning by a fibre‐bonding process. The porosity of the scaffolds was characterized by microcomputerized tomography (µCT) and scanning electron microscopy (SEM). Scaffold degradation behaviour was assessed in solutions containing hydrolytic enzymes (α‐amylase and lipase) in physiological concentrations, in order to simulate in vivo conditions. Mechanical properties were also evaluated in compression tests. The results show that these scaffolds exhibit adequate porosity and mechanical properties to support cell adhesion and proliferation and also tissue ingrowth upon implantation of the construct. The results of the degradation studies showed that these starch‐based scaffolds are susceptible to enzymatic degradation, as detected by increased weight loss (within 2 weeks, weight loss in the SPCL samples reached 20%). With increasing degradation time, the diameter of the SPCL and SPLA fibres decreases significantly, increasing the porosity and consequently the available space for cells and tissue ingrowth during implantation time. These results, in combination with previous cell culture studies showing the ability of these scaffolds to induce cell adhesion and proliferation, clearly demonstrate the potential of these scaffolds to be used in tissue engineering strategies to regenerate bone tissue defects. Copyright © 2008 John Wiley & Sons, Ltd.